ProCE Banner Activity

Tardive Dyskinesia in Long-Term Care: Nuances in Detection and Management

Clinical Thought

Read this expert commentary to learn how to improve diagnosis and management of tardive dyskinesia in older patients in long-term care settings, including optimal use of available pharmacologic agents.

Released: April 25, 2024

Expiration: April 24, 2025

Share

Faculty

Sanjay Gupta

Sanjay Gupta, MD

Chief Medical Officer, BryLin Behavioral Health System
Medical Director, Endeavor Health Services
Buffalo, New York
Voluntary Professor, Department of Psychiatry
SUNY at Buffalo, SUNY Upstate Medical University at Syracuse
Psychiatry Division Chief, Supportive and Palliative Care Department
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Teva Pharmaceuticals.

Teva Pharmaceuticals

Faculty Disclosure

Primary Author

Sanjay Gupta, MD

Chief Medical Officer, BryLin Behavioral Health System
Medical Director, Endeavor Health Services
Buffalo, New York
Voluntary Professor, Department of Psychiatry
SUNY at Buffalo, SUNY Upstate Medical University at Syracuse
Psychiatry Division Chief, Supportive and Palliative Care Department
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Sanjay Gupta, MD: consultant/advisor/speaker: AbbVie, Alkermes, Bristol Myers Squibb, Intracellular, Janssen, Neurocrine, Otsuka, Teva, Vanda.